Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Intellipharmaceutics International Inc IPCIQ

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this... see more

Bullboard (GREY:IPCIQ)

View:
Post by Dollarpeeon May 12, 2019 6:30pm

$268M in Sales + FDA Approval = $1++

Dr. Isa Odidi, CEO of Intellipharmaceutics, stated, "We have achieved yet another milestone and believe that this approval demonstrates the Company's ability to successfully take product ...more  
Post by ROUGETRADER719on May 10, 2019 2:18pm

FDA APRROVED OXY big news market missing it

this going to over buck shortly imo
Comment by AstonMartin13on May 08, 2019 10:10pm

RE:RE:RE:RE:RE:RE:RE:Reverse split

Because of the new financing deal. But i am loading up for August!
Comment by biggerron May 07, 2019 9:01pm

RE:RE:RE:RE:RE:RE:Reverse split

why did it hit 32 cents in the morning, if somebody is willing to pay so much maybe some news are leakiing
Comment by biggerron Apr 29, 2019 3:02pm

RE:RE:RE:RE:RE:Reverse split

this patent fight with Purdue reminds me of the BB's patent fight in the early 2000s with another company which BB eventually won, leading its stock to multiply only to be destroyed later by Apple ...more  
Comment by biggerron Apr 24, 2019 3:58pm

RE:RE:RE:RE:Reverse split

the only valuable asset IPCI has is this Oxy anti-abuse drug, everything else is garbage. It's the only junior with the PDUFA date that I know of, anybody knows any others?
Comment by biggerron Apr 17, 2019 12:36pm

RE:RE:RE:Reverse split

I'm holding out for the PDUFA in August, could be a multibagger if approved which is almost guaranteed, IMHO of course
Comment by biggerron Apr 17, 2019 12:00am

RE:RE:Reverse split

the only reason to hold IPCI is the Oxy anti-abuse pill and maybe potentially some CBD drugs
Post by Malfuncionon Apr 12, 2019 1:25pm

Reverse split

Has this been done already
Comment by biggerron Apr 11, 2019 3:04pm

RE:loaded up for August.

when FDA gives you the PDUFA date that's pretty much like it's approved and the cap is only $9 mil., we talking about sales in $ hundreds of millions
Post by AstonMartin13on Apr 11, 2019 11:41am

loaded up for August.

if drops il buy more.
Comment by biggerron Apr 10, 2019 4:37pm

RE:RE:it's a buy today for me

drug abuse prevention is a billion dollar market in the US, it doesn't look like the drug will be rejected again. Lightning doesn't strike twice
Comment by Mexymaxon Apr 05, 2019 12:56pm

RE:it's a buy today for me

Yep, the land of the brave and the home of the free continues to be a shining beacon in ....... almost nothing!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities